# Global ex US Research Enhanced Index Equity Active UCITS ETF - USD (JXUD) **Page:** https://fundology.uk/fund/jxud · ISIN IE000QC2YB58 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, JXUD (Global ex US Research Enhanced Index Equity Active UCITS ETF - USD, ISIN IE000QC2YB58) closed at $24.95 on the London Stock Exchange. Its ongoing charge is 0.31% a year (about £31 on £10,000). ## Summary JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD is an exchange-traded fund (ETF) from JPMorgan, launched in 2026. It tracks the No Underlying Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.31% a year — about £31 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year. Latest close: **$24.95** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | JXUD | | ISIN | IE000QC2YB58 | | Category | Global shares | | Type | ETF | | Provider | JPMorgan | | Income | Distributing | | Ongoing charge | 0.31% a year (£31 per £10,000) | | Fund size | £447k | | Launched | 2026 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 16/06/2026 | ## Charges compared with similar funds Ongoing charge of JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD 0.31% a year. Compared on 14/11/2026, 69 of the 207 other global share funds charge more, 0 the same and 138 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.31%** per year (as of 13/11/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds As of 13/11/2026, JXUD holds 286 positions, according to its published holdings. The largest is ASML at 2.80% of the fund; the ten largest make up 14.8%. ### Top holdings Largest positions (as of 13/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 2.80% | | 2 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 1.71% | | 3 | Allianz | [ALV](https://fundology.uk/stock/ALV) | 1.48% | | 4 | Siemens | [SIE](https://fundology.uk/stock/SIE) | 1.44% | | 5 | Roche | [RO](https://fundology.uk/stock/RO) | 1.35% | | 6 | Nestle | [NESN](https://fundology.uk/stock/NESN) | 1.30% | | 7 | HSBC | [HSBA](https://fundology.uk/stock/HSBA) | 1.20% | | 8 | Shell | [SHEL](https://fundology.uk/stock/SHEL) | 1.20% | | 9 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 1.16% | | 10 | Royal Bank of Canada | [RY](https://fundology.uk/stock/RY) | 1.15% | ## Where it invests Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed. ### By sector As published for the fund, as of 06/11/2026. | Sector | Weight | |---|---| | Banks | 20.1% | | Industrial Cyclicals | 12.1% | | Basic Industries | 9.1% | | Technology - Semi & Hardware | 8.5% | | Pharm/MedTech | 7.8% | | Insurance | 6.5% | | Energy | 5.1% | | Retail | 4.4% | | Other sectors | 26.3% | ### By country Added up from the fund’s published holdings, as of 06/11/2026. | Country | Weight | |---|---| | Japan | 20.2% | | United Kingdom | 14.5% | | Canada | 12.7% | | France | 10.0% | | Germany | 9.5% | | Switzerland | 7.0% | | Australia | 6.1% | | Netherlands | 5.5% | | Other countries | 14.5% | ### By type of asset Added up from the fund’s published holdings, as of 06/11/2026. | Type of asset | Weight | |---|---| | Equity | 99.8% | | Cash and money market | 0.2% | All 286 holdings: https://fundology.uk/fund/jxud/holdings ## Questions people ask **What is the ongoing charge of JXUD?** The ongoing charge of JXUD is 0.31% a year — about £31 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD 0.31% a year. Compared on 14/11/2026, 69 of the 207 other global share funds charge more, 0 the same and 138 less (share classes counted once). **Is JXUD accumulating or distributing?** JXUD is distributing: income is paid out to holders as cash, usually a few times a year. It pays out quarterly. **What is the ISIN of JXUD?** The ISIN of JXUD is IE000QC2YB58. An ISIN identifies one exact share class of a fund; JXUD is its ticker on the London Stock Exchange. **What does JXUD hold?** As of 13/11/2026, JXUD holds 286 positions, according to its published holdings. The largest is ASML at 2.80% of the fund; the ten largest make up 14.8%. Its ten largest holdings are ASML (2.80%), AstraZeneca (1.71%), Allianz (1.48%), Siemens (1.44%), Roche (1.35%), Nestle (1.30%), HSBC (1.20%), Shell (1.20%), Novartis (1.16%) and Royal Bank of Canada (1.15%). ## Fund documents - [Fund page at J.P. Morgan Asset Management](https://am.jpmorgan.com/gb/en/asset-management/per/products/jpm-global-ex-us-research-enhanced-index-equity-active-ucits-etf-usd-dist-ie000qc2yb58) - [Key investor information document (KIID)](https://wl.fundsquare.net/serv/down-doc/request?cdClient=jpmorgan&isin=IE000QC2YB58&docTypeCode=KIID&docLang=EN&docCountry=GB) - Links checked 12/10/2026. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.